Alyeska Investment Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$2.14M Hold
2022
Q4
$2.77M Hold
2022
Q3
$2.48M Buy
2022
Q2
Sell
2022
Q1
$3.68M Buy
2021
Q4
Sell
2021
Q3
$12.5M Sell
2021
Q2
$21.1M Sell
2021
Q1
$13.9M Sell
2020
Q4
$22.2M Buy
2020
Q3
$2.26M Buy